Cimicoxib

CAS No. 265114-23-6

Cimicoxib( UR-8880 | UR8880 | UR8880 | Cimicoxib )

Catalog No. M27969 CAS No. 265114-23-6

Cimicoxib is a potent and selective inhibitor of COX-2 with anti-inflammatory and analgesic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 88 In Stock
2MG 50 In Stock
5MG 72 In Stock
10MG 107 In Stock
25MG 179 In Stock
50MG 263 In Stock
100MG 392 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cimicoxib
  • Note
    Research use only, not for human use.
  • Brief Description
    Cimicoxib is a potent and selective inhibitor of COX-2 with anti-inflammatory and analgesic activity.
  • Description
    Cimicoxib is a potent and selective inhibitor of COX-2 with anti-inflammatory and analgesic activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    UR-8880 | UR8880 | UR8880 | Cimicoxib
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    265114-23-6
  • Formula Weight
    381.81
  • Molecular Formula
    C16H13ClFN3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (327.39 mM)
  • SMILES
    COc1ccc(cc1F)-c1c(Cl)ncn1-c1ccc(cc1)S(N)(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ema M, et al. Screening study for repeated dose and reproductive/developmental toxicity of rubber accelerator, N,N-dicyclohexyl-2-benzothiazolesulfenamide, in rats. Drug Chem Toxicol. 2007;30(3):167-80.
molnova catalog
related products
  • Flunixin meglumin

    Flunixin Meglumin is a potent inhibitor of the enzyme cyclooxygenase used as analgesic agent with anti-inflammatory and antipyretic activity.

  • Sodium salicylate

    Sodium salicylate is a metabolite of acetylsalicylic acid, and functions by inhibiting NF-kB and reduces oxidative stress.

  • COX-2-IN-2

    COX-2-IN-2, a selective inducible COX2 inhibitor, exhibits potent inhibition with an IC50 of 0.24 μM.